Basal cell carcinoma - the most common form of skin cancer. Methods of treatment
DOI:
https://doi.org/10.12775/JEHS.2024.58.011Keywords
cancer, oncology, dermatology, basal cell carcinomaAbstract
Introduction: Basal cell carcinoma is the most common form of skin cancer. The lifetime risk is estimated as 33% to 39% in white men and 23% to 28% in white women. Because of that it is a very crucial disease for public health. In this article will be described main pathways of treatment which are especially recommended and are the most wide used for different types of basal cell carcinoma. Main division of interventions type used in treatment of basal cell carcinoma are surgical (physical) and non-surgical (medical). Surgical (physical) includes surgical standard excision, Mohs micrographic surgery, curettage and cautery, cryosurgery and laser therapy (ablative lasers, pulsed dye lasers). Non-surgical (medical) includes radiotherapy, topical imiquimod, topical 5- fluorouracil, photodynamic therapy, intralesional interferon.
Aim of study: Literature review of the most recommended treatment of basal cell carcinoma.
State of knowledge: In this publication will be desribed a current state of knowledge about basic and the most crucial basal cell carcinoma treatment.
Conclusion: Because of incidence rate of basal cell carcinoma which is very high- there are many reports about treatment of this disease. Treatment of this disease, especially among low risk patients, is very effective.
References
Urban K, Mehrmal S, Uppal P, Giesey RL, Delost GR. The global burden of skin cancer: A longitudinal analysis from the Global Burden of Disease Study, 1990-2017. JAAD Int. 2021 Jan 4;2:98-108. doi: 10.1016/j.jdin.2020.10.013. PMID: 34409358; PMCID: PMC8362234.
Artosi F, Costanza G, Di Prete M, Garofalo V, Lozzi F, Dika E, Cosio T, Diluvio L, Shumak RG, Lambiase S, Di Raimondo C, Campa S, Piscitelli P, Miani A, Bianchi L, Campione E. Epidemiological and clinical analysis of exposure-related factors in non-melanoma skin cancer: A retrospective cohort study. Environ Res. 2024 Jan 11:118117. doi: 10.1016/j.envres.2024.118117. Epub ahead of print. PMID: 38218521.
Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994 May;30(5 Pt 1):774-8. doi: 10.1016/s0190-9622(08)81509-5. PMID: 8176018.
Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010 Mar;146(3):283-7. doi: 10.1001/archdermatol.2010.19. PMID: 20231499.
Teng Y, Yu Y, Li S, Huang Y, Xu D, Tao X, Fan Y. Ultraviolet Radiation and Basal Cell Carcinoma: An Environmental Perspective. Front Public Health. 2021 Jul 22;9:666528. doi: 10.3389/fpubh.2021.666528. PMID: 34368047; PMCID: PMC8339433.
Furudate S, Fujimura T, Tojo G, Haga T, Aiba S. Basal cell carcinoma arising from xeroderma pigmentosum: a case report and an immunohistochemical study. Case Rep Dermatol. 2013 Mar 9;5(1):64-8. doi: 10.1159/000350182. PMID: 23626541; PMCID: PMC3617891.
Goette DK. Basal cell carcinomas arising in seborrheic keratoses. J Dermatol Surg Oncol. 1985 Oct;11(10):1014-6. doi: 10.1111/j.1524-4725.1985.tb01387.x. PMID: 2931463.
Fania L, Didona D, Morese R, Campana I, Coco V, Di Pietro FR, Ricci F, Pallotta S, Candi E, Abeni D, Dellambra E. Basal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines. 2020 Oct 23;8(11):449. doi: 10.3390/biomedicines8110449. PMID: 33113965; PMCID: PMC7690754.
Situm M, Buljan M, Bulat V, Lugović Mihić L, Bolanca Z, Simić D. The role of UV radiation in the development of basal cell carcinoma. Coll Antropol. 2008 Oct;32 Suppl 2:167-70. PMID: 19138022.
Dourmishev LA, Rusinova D, Botev I. Clinical variants, stages, and management of basal cell carcinoma. Indian Dermatol Online J. 2013 Jan;4(1):12-7. doi: 10.4103/2229-5178.105456. PMID: 23439912; PMCID: PMC3573444.
Yoneta A, Horimoto K, Nakahashi K, Mori S, Maeda K, Yamashita T. A Case of Cystic Basal Cell Carcinoma Which Shows a Homogenous Blue/Black Area under Dermatoscopy. J Skin Cancer. 2011;2011:450472. doi: 10.1155/2011/450472. Epub 2010 Sep 23. PMID: 21151522; PMCID: PMC2989656.
Bittner GC, Cerci FB, Kubo EM, Tolkachjov SN. Mohs micrographic surgery: a review of indications, technique, outcomes, and considerations. An Bras Dermatol. 2021 May-Jun;96(3):263-277. doi: 10.1016/j.abd.2020.10.004. Epub 2021 Mar 24. PMID: 33849752; PMCID: PMC8178571.
Shriner DL, McCoy DK, Goldberg DJ, Wagner RF Jr. Mohs micrographic surgery. J Am Acad Dermatol. 1998 Jul;39(1):79-97. doi: 10.1016/s0190-9622(98)70405-0. PMID: 9674401.
Bennett RG. Mohs' surgery. New concepts and applications. Dermatol Clin. 1987 Apr;5(2):409-28. PMID: 3034458.
Clark CM, Furniss M, Mackay-Wiggan JM. Basal cell carcinoma: an evidence-based treatment update. Am J Clin Dermatol. 2014 Jul;15(3):197-216. doi: 10.1007/s40257-014-0070-z. PMID: 24733429.
Johnson TM, Smith NR. Mohs Surgery versus Standard Local Excision for Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Skin Cancer. Facial Plast Surg. 2020 Apr;36(2):133-140. doi: 10.1055/s-0040-1709142. Epub 2020 May 15. Erratum in: Facial Plast Surg. 2020 Apr;36(2):e1. PMID: 32413920.
Luz FB, Ferron C, Cardoso GP. Surgical treatment of basal cell carcinoma: an algorithm based on the literature. An Bras Dermatol. 2015 May-Jun;90(3):377-83. doi: 10.1590/abd1806-4841.20153304. Epub 2015 Jun 1. PMID: 26131869; PMCID: PMC4516103.
Gulleth Y, Goldberg N, Silverman RP, Gastman BR. What is the best surgical margin for a Basal cell carcinoma: a meta-analysis of the literature. Plast Reconstr Surg. 2010 Oct;126(4):1222-1231. doi: 10.1097/PRS.0b013e3181ea450d. PMID: 20885244.
Prickett KA, Ramsey ML. Mohs Micrographic Surgery. 2023 Jul 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 28722863.
Lawrence CM. Mohs surgery of basal cell carcinoma--a critical review. Br J Plast Surg. 1993 Oct;46(7):599-606. doi: 10.1016/0007-1226(93)90114-q. PMID: 8252270.
Dika E, Veronesi G, Patrizi A, De Salvo S, Misciali C, Baraldi C, Mussi M, Fabbri E, Tartari F, Lambertini M. It's time for Mohs: Micrographic surgery for the treatment of high-risk basal cell carcinomas of the head and neck regions. Dermatol Ther. 2020 Jul;33(4):e13474. doi: 10.1111/dth.13474. Epub 2020 May 18. PMID: 32391961.
Dessinioti C, Stratigos AJ. Immunotherapy and Its Timing in Advanced Basal Cell Carcinoma Treatment. Dermatol Pract Concept. 2023 Oct 1;13(4):e2023252. doi: 10.5826/dpc.1304a252. PMID: 37992360; PMCID: PMC10656142.
Oldfield V, Keating GM, Perry CM. Imiquimod: in superficial basal cell carcinoma. Am J Clin Dermatol. 2005;6(3):195-200; discussion 201-2. doi: 10.2165/00128071-200506030-00006. PMID: 15943496.
Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol. 2004 May;50(5):722-33. doi: 10.1016/j.jaad.2003.11.066. PMID: 15097956.
de Macedo EM, Carneiro RC, de Lima PP, Silva BG, Matayoshi S. Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial. BMC Ophthalmol. 2015 Apr 3;15:35. doi: 10.1186/s12886-015-0024-0. PMID: 25885553; PMCID: PMC4450997.
Collier NJ, Rhodes LE. Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities. Molecules. 2020 Nov 18;25(22):5398. doi: 10.3390/molecules25225398. PMID: 33218174; PMCID: PMC7698957.
Wang H, Xu Y, Shi J, Gao X, Geng L. Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis. Photodermatol Photoimmunol Photomed. 2015 Jan;31(1):44-53. doi: 10.1111/phpp.12148. Epub 2014 Nov 25. PMID: 25377432.
Yang X, Dinehart MS. Triple Hedgehog Pathway Inhibition for Basal Cell Carcinoma. J Clin Aesthet Dermatol. 2017 Apr;10(4):47-49. PMID: 28458774; PMCID: PMC5404780.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Paweł Iwańczuk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 343
Number of citations: 0